Clinicians are seeing clear therapeutic benefits of garden power.

Anosmia and B-lines on lung ultrasound are powerfully accurate.

RECOVERY is the world's largest randomised clinical trial of potential COVID-19 treatments.

OSA is common and increasing in prevalence along with obesity rates.

Hydroxychloroquine, chloroquine with or without macrolide yielded worse outcomes.

Even smokers who quite less than 2 years before diagnosis saw a significant survival boost

AI performs better than clinicians, even when CT results are normal.

Especially among those not receiving thromboprophylaxis.

The CDC has also published different COVID-19 outbreak scenarios that have drawn criticism.

Pulmonary vascular endothelialitis, thrombosis and angiogenesis in COVID-19

Hydroxychloroquine may aggravate certain conditions and should be used with caution.

European countries see fewer interventions needed with earlier care for MIS-C.

Maximising the safety of adults with interstitial lung disease, including idiopathic pulmonary fibrosis and pulmonary sarcoidosis, during the COVID-19 pandemic.

Inflammation markers are independently associated with mortality risk.